Business Description
PhenomeX Inc
NAICS : 541713
SIC : 2833
ISIN : US0843101017
Share Class Description:
CELL: Ordinary SharesDescription
PhenomeX Inc is a functional cell biology company that provides live cell biology research tools which deliver deep insights into cellular function and new perspectives on phenomes.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.07 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | -0.27 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -4.03 | |||||
| Beneish M-Score | 1.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.5 | |||||
| 3-Year EBITDA Growth Rate | -85.9 | |||||
| 3-Year EPS without NRI Growth Rate | -61 | |||||
| 3-Year FCF Growth Rate | -31.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 83.54 | |||||
| 9-Day RSI | 76.03 | |||||
| 14-Day RSI | 71.15 | |||||
| 6-1 Month Momentum % | -16.38 | |||||
| 12-1 Month Momentum % | -66.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.24 | |||||
| Quick Ratio | 1.26 | |||||
| Cash Ratio | 0.73 | |||||
| Days Inventory | 395.66 | |||||
| Days Sales Outstanding | 93.62 | |||||
| Days Payable | 179.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.5 | |||||
| Shareholder Yield % | -16.68 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.75 | |||||
| Operating Margin % | -137.6 | |||||
| Net Margin % | -173.4 | |||||
| FCF Margin % | -94.88 | |||||
| ROE % | -83.73 | |||||
| ROA % | -52.39 | |||||
| ROIC % | -86.97 | |||||
| ROC (Joel Greenblatt) % | -165.39 | |||||
| ROCE % | -61.58 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.05 | |||||
| PB Ratio | 0.89 | |||||
| Price-to-Tangible-Book | 1.11 | |||||
| EV-to-EBIT | -0.79 | |||||
| EV-to-EBITDA | -0.9 | |||||
| EV-to-Revenue | 1.35 | |||||
| EV-to-FCF | -1.42 | |||||
| Price-to-Net-Current-Asset-Value | 3.56 | |||||
| Earnings Yield (Greenblatt) % | -126.58 | |||||
| FCF Yield % | -68.97 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers